Teriflunomid

Teriflunomide is an oral immunomodulatory medication used in disease-modifying therapy. It belongs to the class of disease-modifying antirheumatic drugs (DMARDs). This product is supplied by 1 A Pharma GmbH and is intended for oral administration. Teriflunomide 14 mg is commonly prescribed for multiple sclerosis management.

Teriflunomide is primarily used to reduce the frequency of relapses and delay physical disability progression in adults with relapsing forms of multiple sclerosis. It works by modulating the immune system to decrease inflammation in the central nervous system. Patients often ask what teriflunomide is used for, and it is also considered in certain cases of rheumatoid arthritis as part of broader immunomodulatory therapy.

Common effects of teriflunomide may include headache, nausea, diarrhea, and hair thinning. Some users report mild fatigue or dizziness, particularly when starting treatment. These effects are generally temporary and may diminish as the body adjusts to the medication. Regular monitoring is advised to assess individual tolerance.

Teriflunomide should be handled with care, especially by individuals of childbearing potential due to potential fetal risks. Pregnancy must be avoided during treatment and for a defined period after discontinuation. Blood tests are typically required before and during therapy to monitor liver function and blood cell counts. Avoid use if you have severe liver impairment.

Teriflunomide may interact with other medications that affect liver enzymes, such as certain antiepileptics or rifampin. Combining it with immunosuppressants or live vaccines is generally not recommended. Alcohol use should be minimized due to potential additive effects on liver function. Always inform your healthcare provider about all medications and supplements being taken.